These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 2386044)
41. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Giorgiani G; Bozzola M; Locatelli F; Picco P; Zecca M; Cisternino M; Dallorso S; Bonetti F; Dini G; Borrone C Blood; 1995 Jul; 86(2):825-31. PubMed ID: 7606014 [TBL] [Abstract][Full Text] [Related]
42. Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone. Chen YD; Shu SG; Chi CS Acta Paediatr Taiwan; 2001; 42(5):291-6. PubMed ID: 11729706 [TBL] [Abstract][Full Text] [Related]
43. Dose-response relationship in the treatment of hypopituitary children with human growth hormone: a retrospective survey. Job JC; Chaussain JL; Garnier P; Rolland A; Joab N Acta Paediatr Scand Suppl; 1987; 337():93-105. PubMed ID: 3481186 [TBL] [Abstract][Full Text] [Related]
44. [Statural growth following irradiation of the central nervous system for medulloblastoma of the posterior fossa. Retrospective analysis of 45 cases]. Brauner R; Czernichow P; Rappaport R; Lemerle J; Sarrazin D; Hirsch JF; Renier D; Zucker JM Arch Fr Pediatr; 1985 Mar; 42(3):219-23. PubMed ID: 4004484 [TBL] [Abstract][Full Text] [Related]
45. Adult height after cranial irradiation with 24 Gy: factors and markers of height loss. Adan L; Souberbielle JC; Blanche S; Leverger G; Schaison G; Brauner R Acta Paediatr; 1996 Sep; 85(9):1096-101. PubMed ID: 8888925 [TBL] [Abstract][Full Text] [Related]
46. Growth hormone state after completion of treatment with growth hormone. Clayton PE; Price DA; Shalet SM Arch Dis Child; 1987 Mar; 62(3):222-6. PubMed ID: 3566314 [TBL] [Abstract][Full Text] [Related]
47. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. Saggese G; Baroncelli GI; Bertelloni S; Barsanti S J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878 [TBL] [Abstract][Full Text] [Related]
48. Linear growth and final height after treatment for Cushing's disease in childhood. Lebrethon MC; Grossman AB; Afshar F; Plowman PN; Besser GM; Savage MO J Clin Endocrinol Metab; 2000 Sep; 85(9):3262-5. PubMed ID: 10999819 [TBL] [Abstract][Full Text] [Related]
49. Cranial irradiation and early puberty. Ogilvy-Stuart AL; Clayton PE; Shalet SM J Clin Endocrinol Metab; 1994 Jun; 78(6):1282-6. PubMed ID: 8200926 [TBL] [Abstract][Full Text] [Related]
50. Transitory growth hormone deficiency successfully treated with human growth hormone. Trygstad O Acta Endocrinol (Copenh); 1977 Jan; 84(1):11-22. PubMed ID: 576178 [TBL] [Abstract][Full Text] [Related]
51. Age as a determinant of the impact of growth hormone therapy on predicted adult height. Hochberg Z; Leiberman E; Landau H; Koren R; Zadik Z Clin Endocrinol (Oxf); 1994 Sep; 41(3):331-5. PubMed ID: 7955440 [TBL] [Abstract][Full Text] [Related]
52. Growth hormone therapy for 3 years: the OZGROW experience. Cowell CT; Dietsch S; Greenacre P J Paediatr Child Health; 1996 Apr; 32(2):86-93. PubMed ID: 8860379 [TBL] [Abstract][Full Text] [Related]
53. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children. Hibi I; Tanaka T; Tanae A; Kagawa J; Hashimoto N; Yoshizawa A; Shizume K J Clin Endocrinol Metab; 1989 Aug; 69(2):221-6. PubMed ID: 2526818 [TBL] [Abstract][Full Text] [Related]
54. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS. Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724 [TBL] [Abstract][Full Text] [Related]
56. Response to GH Treatment After Radiation Therapy Depends on Location of Irradiation. Rose SR; Carlsson M; Grimberg A; Aydin F; Albanese A; Hokken-Koelega ACS; Camacho-Hubner C J Clin Endocrinol Metab; 2020 Oct; 105(10):e3730-41. PubMed ID: 32706856 [TBL] [Abstract][Full Text] [Related]
57. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation. Haddy TB; Mosher RB; Nunez SB; Reaman GH Pediatr Blood Cancer; 2006 Feb; 46(2):258-61. PubMed ID: 16369923 [TBL] [Abstract][Full Text] [Related]
58. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153 [TBL] [Abstract][Full Text] [Related]
59. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty. Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556 [TBL] [Abstract][Full Text] [Related]
60. Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome. Polgreen LE; Thomas W; Orchard PJ; Whitley CB; Miller BS Mol Genet Metab; 2014 Feb; 111(2):101-6. PubMed ID: 24368158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]